Amicus Therapeutics Inc
NASDAQ:FOLD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Amicus Therapeutics Inc
NASDAQ:FOLD
|
US |
|
Venus Metals Corporation Ltd
ASX:VMC
|
AU |
|
G
|
Grown Rogue International Inc
CNSX:GRIN
|
CA |
|
S
|
Soyo Group Inc
OTC:SOYO
|
US |
|
S
|
Sculptor Capital Management Inc
F:35OB
|
US |
|
O
|
Ostim Endustriyel Yatirimlar ve Isletme AS
IST:OSTIM.E
|
TR |
|
Wellnex Life Ltd
ASX:WNX
|
AU |
|
E
|
Earth Tech Environment PCL
SET:ETC
|
TH |
Wall Street
Price Targets
FOLD Price Targets Summary
Amicus Therapeutics Inc
According to Wall Street analysts, the average 1-year price target for
FOLD
is 15.81 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.
What is FOLD's stock price target?
Price Target
15.81
USD
According to Wall Street analysts, the average 1-year price target for
FOLD
is 15.81 USD
with a low forecast of 14.14 USD and a high forecast of 23.1 USD.
What is Amicus Therapeutics Inc's Revenue forecast?
Projected CAGR
20%
For the last 14 years the
compound annual growth rate for
Amicus Therapeutics Inc's revenue is
27%.
The projected
CAGR
for the next 3 years is
20%.
What is Amicus Therapeutics Inc's Operating Income forecast?
Projected CAGR
124%
The
compound annual growth rate
of Amicus Therapeutics Inc's operating income for the next 3 years is
124%.
